TMO Stock Analysis: Buy, Sell, or Hold?
TMO - Thermo Fisher Scientific, Inc.
$578.61
-13.55 (-2.29%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Jan 29, 2026
0d
Get Alerted When TMO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TMO is fairly valued with market pricing in -0.0% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: TMO is fairly valued with market pricing in -0.0% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$801.53
Based on 6.3% avg growth
INTRINSIC VALUE TODAY
$497.69
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 24.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TMO is currently trading at $578.61, which is considered oversold relative to its 30-day fair value range of $586.22 to $625.98. The stock's valuation (Forward PE: 24.0) is in line with its historical norms (24.0). At these levels, the market is pricing in -0.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, TMO is in a strong uptrend. The price is currently testing key support at $572.21. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $652.61 (+10.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TMO is in a strong uptrend. The price is currently testing key support at $572.21. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $652.61 (+10.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$586.22 -
$625.98
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.1%
Protect Your Profits
Holding TMO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($652.61)
- NEUTRAL: Market pricing in -0.0% annual earnings growth - fairly valued
- CAUTION: Recommendation downgraded due to -7.6% 5-day decline
Fair Price Analysis
30-Day Fair Range
$586.22 -
$625.98
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$572.21
Resistance Level
$643.99
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
24.00
Wall Street Target
$652.61
(+10.2%)
Revenue Growth (YoY)
4.9%
Earnings Growth (YoY)
0.5%
Profit Margin
15.0%
PE vs Historical
24.0 vs 24.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
0%
(market-implied from PE analysis)
1-Year Target
$592.16
(0%)
2-Year Target
$592.16
(0%)
3-Year Target
$592.16
(0%)
3-Yr Target (if PE normalizes)
(PE: 24→24)
$592.27
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.0, Growth: 8.5%)
$757.09
(+28%)
Base:
(SPY PE: 22.3, Growth: 8.5%)
$703.59
(+19%)
Bear:
(PE: 19.0, Growth: 8.5%)
$598.06
(+1%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (35x PE), but valuation improves significantly next year (24x PE) as earnings recover.
Trailing PE: 35.08 | Current EPS (TTM): $17.33
Bull Case
$952.40
(+65%)
Analyst growth 42.4%, PE expands to 38.6
Base Case
$865.82
(+50%)
Market implied 42.4%, PE stable at 35.1
Bear Case
$413.45
(-29%)
Severe decline -20.0%, PE contracts to 29.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 30, 2026 6:02 PM ET
Data refreshes hourly during market hours. Next update: 7:02 PM
Data refreshes hourly during market hours. Next update: 7:02 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TMO showing a specific setup today?
Insider Activity (6 Months)
4
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
BUY
2025-09-29
Val T. Hoyle
SELL
2025-09-23
Ro Khanna
BUY
2025-09-12
Featured in Portfolios
TMO is a key holding in these high-performance investment strategies.
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 57 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$121 | 62 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$263 | 47 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$257 | 58 HOLD |
|
IQV
IQVIA Holdings Inc |
BUY
23 analysts |
$261 | 59 HOLD |
Advanced TMO Option Strategies
Professional options setups generated by AI based on today's TMO price and gamma walls.
